News

Yeda -v- ImClone/Rorer [2007] UKHL 4324 October 2007Members of Chambers acted in an appeal in the House of Lords in July 2007 in the matter of Yeda -v- ImClone/Rorer. The case concerns the anti-cancer threrapy Erbitux® and the approach to time limits in patent entitlement cases under s.37(5) of the Act and the CPC. Peter Prescott QC, Daniel Alexander QC and Andrew […]
Yeda v ImClone/Rorer [2007] UKHL 4324 October 2007Members of Chambers acted in an appeal in the House of Lords in July 2007 in the matter of Yeda -v- ImClone/Rorer. The case concerns the anti-cancer threrapy Erbitux® and the approach to time limits in patent entitlement cases under s.37(5) of the Act and the CPC. Peter Prescott QC, Daniel Alexander QC and Andrew […]
Univ. of Queensland v Siemens Magnet Technology Ltd [2007] EWHC 2258 (Pat)10 October 2007This patent trial, heard by Pumfrey J in late July 2007, concerned superconducting magnets for use in magnetic resonance imaging scanners. The University of Queensland, represented by Peter Prescott QC and Henry Ward, alleged that Siemens’ MRI magnets infringed its patent. Siemens, represented by Michael Tappin (led by Christopher Floyd QC) denied infringement and alleged […]
Monsanto Technology LLC v Cargill International SA [2007] EWHC 2257 (Pat)10 October 2007A patent action in which Monsanto claimed infringement of a patent covering DNA sequences related to its RoundUp Ready® technology, which involves the genetic modification of a plant to express an enzyme that confers resistance to the herbicide glyphosate (RoundUp®). Cargill imported soymeal from Argentina made from RoundUp Ready soy beans. It raised defences of […]
Monsanto Technology LLC v Cargill International SA [2007] EWHC 2257 (Pat)10 October 2007A patent action in which Monsanto claimed infringement of a patent covering DNA sequences related to its RoundUp Ready® technology, which involves the genetic modification of a plant to express an enzyme that confers resistance to the herbicide glyphosate (RoundUp®). Cargill imported soymeal from Argentina made from RoundUp Ready soy beans. It raised defences of […]
Univ. of Queensland v Siemens Magnet Technology Ltd [2007] EWHC 2258 (Pat)10 October 2007This patent trial, heard by Pumfrey J in late July 2007, concerned superconducting magnets for use in magnetic resonance imaging scanners. The University of Queensland, represented by Peter Prescott QC and Henry Ward, alleged that Siemens’ MRI magnets infringed its patent. Siemens, represented by Michael Tappin (led by Christopher Floyd QC) denied infringement and alleged […]
Nichia -v- Argos [2007] Bus LR 1753 (CA)19 July 2007Daniel Alexander QC and James St.Ville acted for Argos in their appeal against the recent decision of the Patents Court (Mr Justice Pumfrey, 23 February 2007) that standard disclosure on obviousness should not normally be ordered in patent actions. Adrian Speck and James Whyte acted for Nichia. The claim is for infringement of patents relating […]
Nichia v Argos [2007] Bus LR 1753 (CA)19 July 2007Daniel Alexander QC and James St.Ville acted for Argos in their appeal against the recent decision of the Patents Court (Mr Justice Pumfrey, 23 February 2007) that standard disclosure on obviousness should not normally be ordered in patent actions. Adrian Speck and James Whyte acted for Nichia. The claim is for infringement of patents relating […]
Ranbaxy Laboratories Ltd v Warner-Lambert Co [2007] IEHC 25610 July 2007A team from chambers (James Mellor QC, Michael Tappin and Jessie Bowhill) recently represented Ranbaxy at the trial in the High Court of Ireland of its claim for a declaration of non-infringement of one of Warner-Lambert’s patents. The litigation concerns the cholesterol-lowering agent atorvastatin (sold by Warner-Lambert as Lipitor ®). Previously Michael Tappin had represented […]
Ranbaxy Laboratories Ltd v Warner-Lambert Co [2007] IEHC 25610 July 2007A team from chambers (James Mellor QC, Michael Tappin and Jessie Bowhill) recently represented Ranbaxy at the trial in the High Court of Ireland of its claim for a declaration of non-infringement of one of Warner-Lambert’s patents. The litigation concerns the cholesterol-lowering agent atorvastatin (sold by Warner-Lambert as Lipitor ®). Previously Michael Tappin had represented […]